Susquehanna International Group
IMVT icon

Susquehanna International Group’s Immunovant IMVT Stock Holding History

Susquehanna International Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.34M Buy
134,400
+14,700
+12% +$381K ﹤0.01% 5053
2025
Q4 		$3.04M Sell
119,700
-120,000
-50% -$2.68M ﹤0.01% 4844
2025
Q3 		$3.86M Buy
239,700
+212,500
+781% +$3.44M ﹤0.01% 4529
2025
Q2 		$435K Sell
27,200
-186,600
-87% -$2.82M ﹤0.01% 9494
2025
Q1 		$3.65M Buy
213,800
+55,400
+35% +$1.16M ﹤0.01% 4261
2024
Q4 		$3.92M Sell
158,400
-2,700
-2% -$76.6K ﹤0.01% 3988
2024
Q3 		$4.59M Buy
161,100
+53,100
+49% +$1.57M ﹤0.01% 3732
2024
Q2 		$2.85M Sell
108,000
-145,000
-57% -$4.12M ﹤0.01% 4414
2024
Q1 		$8.17M Sell
253,000
-189,600
-43% -$6.92M ﹤0.01% 2908
2023
Q4 		$18.6M Buy
442,600
+46,500
+12% +$1.71M ﹤0.01% 1886
2023
Q3 		$15.2M Buy
396,100
+314,800
+387% +$7.12M ﹤0.01% 2061
2023
Q2 		$1.54M Buy
81,300
+44,300
+120% +$826K ﹤0.01% 5700
2023
Q1 		$574K Buy
+37,000
New +$642K ﹤0.01% 8234
2022
Q3 		– Sell
-29,600
Closed -$115K – 13628
2022
Q2 		$115K Sell
29,600
-31,800
-52% -$137K ﹤0.01% 11337
2022
Q1 		$338K Buy
61,400
+26,800
+77% +$167K ﹤0.01% 9981
2021
Q4 		$295K Buy
34,600
+4,600
+15% +$38K ﹤0.01% 10540
2021
Q3 		$261K Sell
30,000
-141,000
-82% -$1.27M ﹤0.01% 10913
2021
Q2 		$1.81M Buy
171,000
+158,700
+1,290% +$2.22M ﹤0.01% 6148
2021
Q1 		$197K Buy
+12,300
New +$324K ﹤0.01% 11435

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Susquehanna International Group's IMVT Position: Q1 2026 in Review

Susquehanna International Group increased its Immunovant (IMVT) stake by 138% in Q1 2026, buying an estimated $9.29M and bringing the position to 617,807 shares worth $15.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2539.

Susquehanna International Group first reported a position in IMVT in Q3 2020 and has held it in 23 quarters since. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Susquehanna International Group held 617,807 shares of Immunovant worth $15.3M as of Q1 2026.
  • Susquehanna International Group bought 358,690 Immunovant shares in Q1 2026, an estimated $9.29M.
  • Immunovant made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2539 holding.
  • Susquehanna International Group first reported a position in Immunovant in Q3 2020 and has held it in 23 quarters since.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.